LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Visual Diagnostic Technique to Advance Early Detection of Neurodegenerative Diseases

By LabMedica International staff writers
Posted on 07 Aug 2024

Parkinson's disease is identified by the buildup of misfolded alpha-synuclein proteins, which are crucial to the function of neural cells in the brain. This condition impacts millions globally, creating substantial hurdles in both early detection and treatment. Typically, Parkinson’s is diagnosed in later stages through clinical observation of physical symptoms, which often delays the application of potential treatments. Early diagnosis currently depends on sophisticated, costly equipment that is not widely accessible, particularly in less developed regions. Researchers have now introduced a novel visual diagnostic approach aimed at improving early detection capabilities for neurodegenerative diseases like Parkinson's.

Named Cap-QuIC (Capillary-enhanced Quaking-Induced Conversion), the techniques developed by researchers at the University of Minnesota (Minneapolis, MN, USA), allows clinicians to visually identify infected samples, enhancing both the affordability and accessibility of testing. Building on their earlier diagnostic advancements, Cap-QuIC employs a simple technique to visually detect misfolded alpha-synuclein proteins. In their research published in npj Biosensing, a peer-reviewed scientific journal from Nature, the team utilized glass capillaries—tiny tubes designed for biological samples—to differentiate between normal and abnormal proteins by observing how liquids behave within these tubes. The effectiveness of Cap-QuIC was validated through testing on tissue samples from white-tailed deer affected by Chronic Wasting Disease, where it demonstrated high levels of sensitivity and specificity in distinguishing diseased samples.


Image: Researcher Peter Christenson holds glass capillary tubes like those used in the study focusing on improving detection of neurodegenerative diseases (Photo courtesy of Thomas and Tonya Seiler, MNPRO)
Image: Researcher Peter Christenson holds glass capillary tubes like those used in the study focusing on improving detection of neurodegenerative diseases (Photo courtesy of Thomas and Tonya Seiler, MNPRO)

"Our Cap-QuIC procedure represents a major advancement in point-of-care neurodegenerative disease diagnostics," said Professor Sang-Hyun Oh, a McKnight Professor and Bordeau Chair in the College of Science and Engineering’s Department of Electrical and Computer Engineering and senior co-author of the paper. "By simplifying the detection process, we can potentially diagnose Parkinson's disease earlier, which is crucial for effective management and treatment."

Related Links:
University of Minnesota


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Thyroid Test
Anti-Thyroid EIA Test

Latest Pathology News

Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
07 Aug 2024  |   Pathology

Study Highlights Biomarker Testing Delays in Lung Cancer Care
07 Aug 2024  |   Pathology

Stain-Free Imaging Platform Matches Standard Cancer Pathology
07 Aug 2024  |   Pathology



ADLM